Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02938403 · ClinicalTrials.gov registry record · NA
In Vivo Experience With NRT to Increase Adherence and Smoking Abstinence
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 517
- Enrollment target
NCT02938403 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 517 participants.
The verdict
NCT02938403, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 517 participants
- Enrollment target
Study Summary
This is a study to determine the efficacy of a smoking cessation intervention (nicotine replacement therapy (NRT) and counseling) done in a systematized manner with participants recruited from the UAB Substance Abuse Program. The definition of In Vivo experience is: use of the NRT medication during the session using specialized counseling focused around their experience of using NRT, including how the use of NRT may help them quit smoking, side effects, and smoking cessation expectancies. In this study those in the In Vivo group will put the patch on during Session 1 and given nicotine gum in Session 2 and will discuss the experience of wearing the patch or chewing the gum while they are in session. The control group will not put on the patch or chew gum during the sessions but will be given standard counseling regarding quitting smoking.
Interventions
- BEHAVIORAL Standard Smoking Cessation Counseling
- BEHAVIORAL In vivo counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 517 participants |
| Start Date | 2017-01 |
| Est. Completion | 2022-10-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02938403
The ClinicalTrials.gov registry entry for NCT02938403 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 517 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Smoking Cessation Counseling is the first listed.
NCT02938403 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02938403 about?
NCT02938403 is a clinical study titled "In Vivo Experience With NRT to Increase Adherence and Smoking Abstinence". This is a study to determine the efficacy of a smoking cessation intervention (nicotine replacement therapy (NRT) and counseling) done in a systematized manner with participants recruited from the UAB Substance Abuse Program. The definition of In Vivo experience is: use of the NRT medication during ...
What is the current status of trial NCT02938403?
This trial is currently completed. It is a NA study. The enrollment target is 517 participants. The study started on 2017-01. Estimated completion is 2022-10-13.
What interventions are being tested in trial NCT02938403?
The interventions under investigation include: Standard Smoking Cessation Counseling (BEHAVIORAL), In vivo counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT02938403?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.